NEE DELHI: The Union health ministry is expected to soon approve Biological E’s Corbevax as a precautionary dose for people over 18 years of age receiving a double vaccine with either Coviescudo either covaxinofficial sources said on Tuesday.
The approval will be based on the recommendations made by the Covid-19 Workgroup of the National Technical Advisory Group on Immunization (NTAGI) last week, the sources told PTI.
If approved by the government, this would be the first time a booster dose of a covid vaccine other than the one used for primary vaccination would be allowed in the country.
“Corbevax will be considered as a precautionary dose after the completion of 6 months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for those over 18 years of age that allow the use of Corbevax as a heterologous vaccine against covid-19 for the administration of precautionary doses in this age group,” said a source.
This will be in addition to existing guidelines for administration of homologous precautionary doses of Covaxin and Covishield vaccines.
India’s first indigenous development RBD The Corbevax protein subunit vaccine is currently being used to inoculate children in the age group of 12 to 14 years in the framework of the Covid-19 immunization program.
The Covid-19 Working Group (CWG), at its meeting on July 20, reviewed data from the phase 3, randomized, double-blind clinical study that evaluated the immunogenicity and safety of the booster dose of the Corbevax vaccine when previously administered to adult volunteers negative for Covid-19 from 18 to 80 years of age vaccinated with two doses of Covishield or Covaxin.
“Upon review of the data, the CWG noted that the Corbevax vaccine may induce a significant increase in antibody titers when given to those who have received Covaxin or Covishield, which is also likely to be protective based on neutralization data,” he said. the fountain. .
The Drug Controller General of India (DCGI) approved Corbevax on June 4 as a precautionary dose for people over 18 years of age.
India began administering precautionary doses of vaccines to health care and frontline workers and those over 60 with comorbidities from January 10.
The country began vaccinating children aged 12 to 14 from March 16 and also removed the comorbidity clause that makes all people over 60 years of age eligible for the precautionary dose of the Covid vaccine.
On April 10, India began administering precautionary doses of COVID-19 vaccines to everyone over the age of 18.
The Times of India es un popular periódico diario en inglés de gran formato en la India. Tiene la circulación más grande de todos los diarios en inglés del mundo, en todos los formatos. Es propiedad de The Times Group, que a su vez es propiedad de la familia Sahu Jain.